Dachaigh › Galar Ae Steatotic › Arizona › Chandler
Sgrùdaidhean clionaigeach Galar Ae Steatotic ann an Chandler, AZ
Tha 10 sgrùdaidhean airson Galar Ae Steatotic a’ lorg phàirtichean aig làraichean ann agus timcheall air Chandler (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
A’ fastadhÌre 3
- 89bio Clinical Study Site, Chandler
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
A’ fastadhÌre 3
- 89bio Clinical Study Site, Chandler
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
A’ fastadhÌre 2
- Arizona Liver Health, Chandler
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
A’ fastadhÌre 3
- The Institute for Liver Health II dba Arizona Clinical Trials - Chandler, Chandler
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
A’ fastadhÌre 3
- Akero Clinical Study Site, Chandler
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
A’ fastadhÌre 2
- Arizona Liver Health, Chandler
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
A’ fastadhÌre 2
- GSK Investigational Site, Chandler
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
A’ fastadhÌre 3
- GSK Investigational Site, Chandler
A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
A’ fastadhÌre 2
- GSK Investigational Site, Chandler
Non-Invasive Quantification of Liver Health in NASH (N-QUAN)
A’ fastadh
- Arizona Liver Health, Chandler
Sgrùdaidhean Galar Ae Steatotic ann am bailtean eile
- San Antonio, TX17 sgrùdaidhean
- New York City, NY16 sgrùdaidhean
- Miami, FL16 sgrùdaidhean
- San Diego, CA14 sgrùdaidhean
- Austin, TX13 sgrùdaidhean
- Houston, TX13 sgrùdaidhean
- Richmond, VA12 sgrùdaidhean
- Tucson, AZ10 sgrùdaidhean
- Hialeah, FL9 sgrùdaidhean
- Dallas, TX9 sgrùdaidhean
- Orlando, FL9 sgrùdaidhean
- St. Louis, MO9 sgrùdaidhean
Sgrùdaidhean eile ann an Chandler
- Aillse a' bhroilleach5 sgrùdaidhean
- Aillse Sgamhain Neo-chealla-beag5 sgrùdaidhean
- Aillse colorectal5 sgrùdaidhean
- Obesity5 sgrùdaidhean
- Galaran Cnàmhaidh5 sgrùdaidhean
- Galaran an Ae4 sgrùdaidhean
- Ro-throm4 sgrùdaidhean
- Diabaitis Seòrsa 24 sgrùdaidhean
- Ailse metastatach4 sgrùdaidhean
- Galar Alzheimer3 sgrùdaidhean
- Galarachd Cardiovasculach3 sgrùdaidhean
- Aillse colon3 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.